A series of novel 1,2,3-triazole-linked isosteviol derivatives were synthesized.
Their cytotoxicities were assessed against HCT-116 and JEKO-1cell lines.
Compound 10b is promising anticancer agent against HCT-116 (IC50 = 2.987 ± 0.098 μM).
HQSAR studies revealed good predictive model.